Climb Bio, Inc.
CLYM
Revenue
0.00
0.000.00%
-Assets
226.02M
▲116.68M▲106.72%
3 Months ChangeLiabilities
3.74M
▲791.00k▲26.81%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-15
Form 8-K
ID: 0001193125-24-237196
2024-10-02
Form 8-K
ID: 0001193125-24-231167
2024-08-27
Form 8-K
ID: 0001193125-24-207854
2024-08-26
Form 8-K
ID: 0001193125-24-206655
2024-08-14
Form 8-K
ID: 0000950170-24-096627
2024-08-14
Form 10-Q
ID: 0000950170-24-096626
2024-06-27
Form 8-K
ID: 0001193125-24-170599
2024-06-26
Form 8-K
ID: 0001193125-24-169077
2024-06-12
Form 8-K
ID: 0001193125-24-159994
2024-05-15
Form 10-Q
ID: 0000950170-24-059995